<DOC>
	<DOCNO>NCT00187382</DOCNO>
	<brief_summary>In woman 26 30 week gestation risk threaten early birth , baby 14 day give single course antenatal corticosteroid ( ACS ) , repeat course ACS every 14 day 33 week ' gestational age low risk illness death baby compare repeated course placebo . Children assess 2 year 5 year neurodevelopmental impairment .</brief_summary>
	<brief_title>Multiple Courses Antenatal Corticosteroids Preterm Birth Study ( MACS )</brief_title>
	<detailed_description>In woman 26 30 week gestation , increase risk preterm birth remain undelivered 14 day follow single course antenatal corticosteroid ( ACS ) , multiple course ACS every 14 day 33 week effective reduce risk perinatal neonatal mortality significant neonatal morbidity , compare placebo . 18-24 Month Follow-up : Children ( 18-24 month correct gestational age ) assess Bayley Scales Infant Development ( Second Edition ) determine neurodevelopmental impairment . 5 Year Follow-up ( MACS-5 ) : Children assess use Child Behaviour Checklist ( 1 1/2 - 5 ) Behaviour Rating Inventory Executive Function ( Preschool version ) determine neurocognitive function .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Women previously receive one complete course ACS , least 14 day ago continue increase risk preterm birth Gestational age great ≥ 26 week gestational age &lt; 31 week Women require chronic dos corticosteroid secondary medical condition Women contraindication corticosteroid Women clinical evidence chorioamnionitis ( temperature ≥ 38°c ) Known lethal congenital anomaly ( e.g . anencephaly )</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>antenatal corticosteroid</keyword>
	<keyword>preterm birth</keyword>
	<keyword>multiple versus single dos</keyword>
	<keyword>follow-up</keyword>
</DOC>